Qelbree

Indicated For

ADHD

About This Medication

# SupernusSupport Patient Assistance Program Patient Guide: How to Get Qelbree (viloxazine) at Low or No Cost Qelbree (viloxazine) is a prescription medication used to treat **Attention Deficit Hyperactivity Disorder (ADHD)** in children and adults. The **SupernusSupport Patient Assistance Program** from Supernus Pharmaceuticals helps eligible patients get Qelbree at low or no cost if they are uninsured or underinsured.[1][7] ## About Qelbree (viloxazine) Qelbree is an extended-release capsule taken once daily. It works differently from stimulant medications by targeting norepinephrine in the brain to improve focus, attention, and impulse control. It's approved for ADHD in patients aged 6 years and older. Common side effects may include sleepiness, decreased appetite, nausea, and fatigue. Always take it as prescribed by your doctor and discuss any concerns with them.[1] This guide explains the SupernusSupport Patient Assistance Program (PAP), designed for patients who struggle to afford their medication due to limited insurance or income. The program provides free or low-cost Qelbree to those who qualify, but eligibility is **not guaranteed**.[1][7] ## Who Qualifies for the Program? The program is primarily for **uninsured or underinsured U.S. residents** who meet income guidelines and lack adequate prescription coverage. Key requirements include: - U.S. legal residency (confirmed on the form).[1] - No or limited prescription drug coverage. - **Household income typically below a certain percentage of the Federal Poverty Level (FPL)**, though exact thresholds are not publicly specified in available sources. Eligibility is reviewed case-by-case.[7] - Patient and prescriber signatures on the enrollment form.[1] **Important:** Medicare Part D patients are **not eligible** and cannot use Part D benefits with this program. Medications received do not count toward Medicare True Out-of-Pocket (TrOOP) expenses.[1] ## Income Eligibility Breakdown Specific income limits (e.g., 400% FPL) are not detailed in program documents. Eligibility depends on household size and income, verified during review. Here's a general table based on typical PAP structures (consult Supernus for your situation): | Household Size | Estimated Max Income (e.g., ~400% FPL, 2026 guidelines)* | |----------------|-----------------------------------------------------| | 1 (Individual) | ~$60,000 | | 2 (Couple) | ~$81,000 | | 3 | ~$102,000 | | 4 | ~$123,000 | *Notes: These are illustrative based on standard FPL multiples; actual thresholds not specified. 'Eligibility not guaranteed; details not specified in available sources.' Call (866) 398-0833 for personalized info.[1][7] ## Insurance Requirements - **Not for patients with Medicare Part D**: You cannot enroll if using Part D benefits, and program meds won't apply to your deductible.[1] - Best for uninsured or underinsured patients whose insurance doesn't cover Qelbree adequately.[7] - Benefits verification is available—complete form sections for insurance check.[1] Supernus Support can help verify coverage Monday-Friday, 8:30AM–6:30PM ET.[2] ## Step-by-Step Application Process 1. **Download the Form**: Get the SupernusSupport Enrollment Form for Qelbree from www.Qelbree.com or call (866) 398-0833.[1] 2. **Fill Out Patient Info**: Provide name, DOB, sex, address, phone/email, U.S. residency status, and preferred contact method.[1] 3. **Prescriber Completes Sections**: Your doctor fills benefits verification (A, B, C, D, F) or full PAP (all sections), including prescription details and signature (Section D).[1] 4. **Sign Required Sections**: Patient signs (F), prescriber signs (D, E if needed).[1] 5. **Gather Documents**: No additional proofs listed, but complete form is key. Incomplete forms delay processing.[1] 6. **Fax the Form**: Send to 1-855-998-1515. Do not mail unless specified.[1][3][4] 7. **Follow Up**: Call (866) 398-0833 for status. Available M-F, 8:30AM-6:30PM ET.[2] **Required Documents**: - Completed enrollment form - Prescriber signature - Patient signature[1] Work with your healthcare provider—they must sign and may initiate benefits verification.[7] ## Timeline and Delivery Processing time is not specified in sources. Expect review after fax receipt; call for updates. Once approved, medication ships directly (delivery method not detailed—likely to prescriber or patient home). Program may provide supply for up to a year, but reauthorization could apply. Supernus may change/discontinue anytime without notice, except Medicare enrollees get benefits through year-end.[1] ## Alternatives if Denied or Ineligible - **Copay Savings Cards**: Ask your doctor about Supernus commercial savings options for insured patients.[2] - **Other Resources**: Check NeedyMeds, RxAssist, or RxHope for Qelbree alternatives.[7] - **State Programs**: Look into state pharmaceutical assistance. - **Generic Options**: No generics for Qelbree yet; discuss ADHD alternatives like stimulants with your doctor. - **Reapply**: Fix issues and resubmit if denied for incompleteness. - **Grants**: Supernus offers organizational grants, but not direct patient aid.[2] No biosimilar alternatives available.[program details] ## Disclaimer This guide is for informational purposes based on available sources as of 2026. Program details can change; **eligibility not guaranteed**.[1] Contact SupernusSupport at (866) 398-0833 or www.Qelbree.com for latest info. Consult your doctor before starting Qelbree. Not medical advice. Supernus may discontinue program without notice.[1][2]

Program information last verified: March 30, 2026